The pharmaceutical field is experiencing a major shift in diabetes treatment with the arrival of GLP-1 transdermal devices. These revolutionary vehicles offer a likely simple option to injections for individuals dealing with diabetes. By avoiding the requirement for frequent pokes, GLP-1 adhesive